Treatment for Type-2-Diabetes News: Fixed Combination of DPP-4 and SGLT-2 Inhibitors

被引：0
|
作者：
不详
机构：
来源：
DIABETES STOFFWECHSEL UND HERZ | 2018年 / 27卷 / 03期
关键词：
TYPE-2; DIABETES-MELLITUS; MILLION PEOPLE; SITAGLIPTIN; THERAPY; RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [31] Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors
    Amanda M. Farr
    John J. Sheehan
    Matthew Brouillette
    David M. Smith
    Stephen S. Johnston
    Iftekhar Kalsekar
    Advances in Therapy, 2016, 33 : 68 - 81
  • [32] Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors
    Farr, Amanda M.
    Sheehan, John J.
    Brouillette, Matthew
    Smith, David M.
    Johnston, Stephen S.
    Kalsekar, Iftekhar
    ADVANCES IN THERAPY, 2016, 33 (01) : 68 - 81
  • [33] Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
    S., Ametov A.
    Karpova, E., V
    DIABETES MELLITUS, 2010, 13 (02): : 69 - 75
  • [34] Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
    Abd A. Tahrani
    Milan K. Piya
    Anthony H. Barnett
    Advances in Therapy, 2009, 26 : 249 - 262
  • [35] Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention
    Laeeq, Tooba
    Ahmed, Maheen
    Sattar, Hina
    Zeeshan, Muhammad Hamayl
    Ali, Meher Binte
    CANCERS, 2024, 16 (07)
  • [36] Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
    Zerilli, Tina
    Pyon, Eunice Y.
    CLINICAL THERAPEUTICS, 2007, 29 (12) : 2614 - 2634
  • [37] Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
    Tahrani, Abd A.
    Piya, Milan K.
    Barnett, Anthony H.
    ADVANCES IN THERAPY, 2009, 26 (03) : 249 - 262
  • [38] Linagliptin: A New DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
    Toth, Peter P.
    POSTGRADUATE MEDICINE, 2011, 123 (04) : 46 - 53
  • [39] A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes
    Cha, Seon-Ah
    Park, Yong-Moon
    Yun, Jae-Seung
    Lim, Tae-Seok
    Song, Ki-Ho
    Yoo, Ki-Dong
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    LIPIDS IN HEALTH AND DISEASE, 2017, 16 : 1 - 8
  • [40] Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
    Deacon, Carolyn F.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
12345